News
Consolidated sales totaled €1,098 million in the first quarter of 2025, up 13.7% as reported from €965 million in first quarter of 2024. Organic growth (at constant exchange rates and scope of consolidation) stood at +12.7%, above expectations.
Swipe to discover more
-
bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of LUMED™ APSS™, an advanced clinical decision support system (CDSS) designed to enhance antimicrobial stewardship programs (ASP) and improve patient outcomes. -
The Growing Problem of Listeria and Listeriosis: What are the risks and how can you stay protected?
Listeria monocytogenes is a type of bacteria that can contaminate food and cause listeriosis – a potentially life-threatening illness if not treated properly. In many respects a perfectly designed bacterial contaminant, Listeria remains hardy even in the face of aggressive cleaning and sanitizing. Unlike many foodborne bacteria, it can survive and even grow even under refrigeration, tolerates salty environments and thrives when it comes into contact with food. -
bioMérieux Embarks its Customers in a Circular Economy Initiative
BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19